Darren Ashcroft
Darren Ashcroft
Professor of Pharmacoepidemiology, University of Manchester
Verified email at manchester.ac.uk
Cited by
Cited by
Global epidemiology of psoriasis: a systematic review of incidence and prevalence
R Parisi, DPM Symmons, CEM Griffiths, DM Ashcroft
Journal of Investigative Dermatology 133 (2), 377-385, 2013
Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies
C Kongkaew, PR Noyce, DM Ashcroft
Annals of Pharmacotherapy 42 (7-8), 1017-1025, 2008
Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence
R Parisi, DP Symmons, CE Griffiths, DM Ashcroft
J Invest Dermatol 133 (2), 377-85, 2013
Causes of medication administration errors in hospitals: a systematic review of quantitative and qualitative evidence
RN Keers, SD Williams, J Cooke, DM Ashcroft
Drug safety 36 (11), 1045-1067, 2013
An in-depth investigation into causes of prescribing errors by foundation trainees in relation to their medical education: EQUIP study
T Dornan, D Ashcroft, H Heathfield, P Lewis, J Miles, D Taylor, M Tully, ...
London: General Medical Council, 1-215, 2009
Prevalence, incidence and nature of prescribing errors in hospital inpatients
PJ Lewis, T Dornan, D Taylor, MP Tully, V Wass, DM Ashcroft
Drug safety 32 (5), 379-389, 2009
Interventions for vitiligo
ME Whitton, M Pinart, J Batchelor, J Leonardi‐Bee, U Gonzalez, Z Jiyad, ...
Cochrane Database of Systematic Reviews, 2015
Prevalence and nature of medication administration errors in health care settings: a systematic review of direct observational evidence
RN Keers, SD Williams, J Cooke, DM Ashcroft
Annals of Pharmacotherapy 47 (2), 237-256, 2013
Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials
DM Ashcroft, P Dimmock, R Garside, K Stein, HC Williams
Bmj 330 (7490), 516, 2005
Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality
British Journal of Dermatology 141 (2), 185-191, 1999
Differential drug survival of biologic therapies for the treatment of psoriasis: a prospective observational cohort study from the British Association of Dermatologists …
RB Warren, CH Smith, ZZN Yiu, DM Ashcroft, JNWN Barker, AD Burden, ...
Journal of Investigative Dermatology 135 (11), 2632-2640, 2015
Prevalence of adverse drug events in ambulatory care: a systematic review
SV Taché, A Sönnichsen, DM Ashcroft
Annals of Pharmacotherapy 45 (7-8), 977-989, 2011
The causes of and factors associated with prescribing errors in hospital inpatients
MP Tully, DM Ashcroft, T Dornan, PJ Lewis, D Taylor, V Wass
Drug safety 32 (10), 819-836, 2009
Incidence, clinical management, and mortality risk following self harm among children and adolescents: cohort study in primary care
C Morgan, RT Webb, MJ Carr, E Kontopantelis, J Green, ...
bmj 359, 2017
Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology …
MM Soliman, DM Ashcroft, KD Watson, M Lunt, DPM Symmons, KL Hyrich
Annals of the rheumatic diseases 70 (4), 583-589, 2011
Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies
DM Ashcroft, P Quinlan, A Blenkinsopp
Pharmacoepidemiology and drug safety 14 (5), 327-332, 2005
Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
AA Saad, DM Ashcroft, KD Watson, KL Hyrich, PR Noyce, DPM Symmons
Arthritis research & therapy 11 (2), 1-9, 2009
Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis
DM Ashcroft, ALW Po, HC Williams, CEM Griffiths
Bmj 320 (7240), 963-967, 2000
Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis
M Panagioti, K Khan, RN Keers, A Abuzour, D Phipps, E Kontopantelis, ...
bmj 366, 2019
Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trials.
AA Saad, DPM Symmons, PR Noyce, DM Ashcroft
The Journal of Rheumatology 35 (5), 883-890, 2008
The system can't perform the operation now. Try again later.
Articles 1–20